TALROSKY
Live / Applied — Third extension granted (statement of use) (as of 13 Mar 2026)
What this means for you
Not registered yet, but its 13 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98267452
- Mark type
- Stylized text
- Filed
- 13 Nov 2023
- Published for opposition
- 13 Aug 2024
- Attorney of record
- Jenifer deWolf Paine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
Owner
- NUVATION BIO INC., New York, NY, US
- ANHEART THERAPEUTICS LLC, NEW YORK, NY, US
- AnHeart Therapeutics Inc, New York, NY, US
- AnHeart Therapeutics Inc, New York, NY, US
Prosecution history
- 14 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2026 — SOU EXTENSION 3 GRANTED
- 13 Mar 2026 — SOU EXTENSION 3 FILED
- 13 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Oct 2025 — SOU EXTENSION 2 GRANTED
- 08 Oct 2025 — SOU EXTENSION 2 FILED
- 08 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2025 — SOU EXTENSION 1 GRANTED
- 02 Apr 2025 — SOU EXTENSION 1 FILED
- 02 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Mar 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Nov 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT